As the tumour proliferation rate was similar between codon 273 mutant, other TP53 mutant and TP53 WT groups, it suggests that the improved survival of codon 273 mutant patients might not be due to decreased tumour proliferation activity. This evidence concerns the gene TP53 and neoplasm.